Preemption Summary Judgment Granted In Incretin-Mimetic Multidistrict Litigation
SAN DIEGO — The California federal judge overseeing the incretin mimetic multidistrict litigation on Nov. 9 granted summary judgment to five makers or promoters of the diabetes drugs, finding clear evidence...To view the full article, register now.
Already a subscriber? Click here to view full article